#percutaneous_coronary_intervention

Two Locks Beat One: Aspirin Holds Its Ground After STEMI

Medically Reviewed by Dr. Şekip Altunkan on Nov 20, 2026.
Cardiologist talks with an older male heart attack patient in a hospital bed, a small cup of tablets on the tray table

AI-generated image · VitalsDaily

Key Takeaway

In a randomized trial of 2,216 patients receiving emergency stents for the most severe type of heart attack, skipping aspirin and relying on low-dose prasugrel alone did not hold up against standard dual therapy. Death, stroke or heart attack occurred in 11.0% of patients without aspirin versus 8.5% with it at 12 months. Bleeding was lower without aspirin, but the clotting price suggests aspirin still belongs in the first year after a STEMI.

The Tablet Chewed in the Back of the Ambulance

Picture a 62-year-old man who wakes at 5 a.m. with a crushing weight on his chest. Within minutes a paramedic records an ECG showing ST-segment elevation, the electrical signature of a coronary artery that has been completely sealed off by a blood clot. Before anything else happens, he is handed aspirin and told to chew it. For decades that gesture has been as reflexive as starting oxygen.

What follows is primary percutaneous coronary intervention, or PCI: a thin catheter threaded from the wrist or groin to the heart, a balloon to crack open the blockage…

Medically reviewed by

Dr. Şekip Altunkan

Dr. Şekip Altunkan is an internal medicine specialist with extensive clinical experience. He trained at Hacettepe University Faculty of Medicine and later served as an Associate Professor in Internal Medicine. He founded and led the Metropol Internal Medicine and Hypertension Clinic in Ankara, pioneering non-invasive Electron Beam Tomography (EBT) cardiac imaging, arterial-stiffness measurement, and nationwide Holter monitoring. He currently practices at his private clinic in Ankara, focusing on hypertension, vascular health, cholesterol, diabetes and heart disease. He has published widely in national and international journals, serves as a peer reviewer for several international journals, and is the author of the book "Questions and Answers on Hypertension."

Share this article